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The reprogramming of fibroblasts to induced plurip-
otent stem cells (iPSCs) raises the possibility that
a somatic cell could be reprogrammed to an alterna-
tive differentiated fate without first becoming a stem/
progenitor cell. A large pool of fibroblasts exists in
the postnatal heart, yet no single ‘‘master regulator’’
of direct cardiac reprogramming has been identified.
Here, we report that a combination of three develop-
mental transcription factors (i.e., Gata4, Mef2c, and
Tbx5) rapidly and efficiently reprogrammed post-
natal cardiac or dermal fibroblasts directly into differ-
entiated cardiomyocyte-like cells. Induced cardio-
myocytes expressed cardiac-specific markers, had
a global gene expression profile similar to cardio-
myocytes, and contracted spontaneously. Fibro-
blasts transplanted into mouse hearts one day after
transduction of the three factors also differentiated
into cardiomyocyte-like cells. We believe these find-
ings demonstrate that functional cardiomyocytes
can be directly reprogrammed from differentiated
somatic cells by defined factors. Reprogramming
of endogenous or explanted fibroblasts might pro-
vide a source of cardiomyocytes for regenerative
approaches.INTRODUCTION
Heart disease is a leading cause of adult and childhoodmortality.
The underlying pathology is typically loss of cardiomyocytes that
leads to heart failure or improper development of cardiomyo-
cytes during embryogenesis that leads to congenital heartmalformations. Because postnatal cardiomyocytes have little
or no regenerative capacity, current therapeutic approaches
are limited. Embryonic stem cells possess clear cardiogenic
potential, but efficiency of cardiac differentiation, risk of tumor
formation, and issues of cellular rejection must be overcome
(Ivey and Srivastava, 2006; Laflamme et al., 2007; Nussbaum
et al., 2007; van Laake et al., 2008). The ability to reprogram
fibroblasts into induced pluripotent stem cells (iPSCs) with four
defined factors might address some of these issues by providing
an alternative source of embryonic-like stem cells (Takahashi
and Yamanaka, 2006). However, generating sufficient iPSC-
derived cardiomyocytes that are pure and mature and that can
be delivered safely remains challenging (Zhang et al., 2009).
The human heart is composed of cardiomyocytes, vascular
cells, and cardiac fibroblasts. In fact, cardiac fibroblasts com-
prise over 50% of all the cells in the heart (Baudino et al.,
2006; Camelliti et al., 2005; Snider et al., 2009). Cardiac fibro-
blasts are fully differentiated somatic cells that provide support
structure, secrete signals, and contribute to scar formation
upon cardiac damage (Ieda et al., 2009). Fibroblasts arise from
an extracardiac source of cells known as the proepicardium,
and do not normally have cardiogenic potential (Snider et al.,
2009). The large population of endogenous cardiac fibroblasts
is a potential source of cardiomyocytes for regenerative therapy
if it were possible to directly reprogram the resident fibroblasts
into beating cardiomyocytes. Unfortunately, although embryonic
mesoderm can be induced to differentiate into cardiomyocytes
(Takeuchi and Bruneau, 2009), efforts to accomplish this in
somatic cells have thus far been unsuccessful, and to our knowl-
edge, no ‘‘master regulator’’ of cardiac differentiation, like MyoD
for skeletal muscle (Davis et al., 1987), has been identified
to date.
The generation of iPSCs suggests that a specific combination
of defined factors, rather than a single factor, could epigeneti-
cally alter the global gene expression of a cell and allow greater
plasticity of cell type than previously appreciated. ConsistentCell 142, 375–386, August 6, 2010 ª2010 Elsevier Inc. 375
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Figure 1. Screening for Cardiomyocyte-
Inducing Factors
(A) Schematic representation of the strategy to test
candidate cardiomyocyte-inducing factors.
(B) Morphology and characterization of fibroblast-
like cells migrating from aMHC-GFP heart
explants. Phase contrast (left), GFP (middle), and
Thy-1 immunostaining (right). Insets are high-
magnification views. See also Figure S1.
(C) Thy-1+/GFP cells were FACS sorted from
explant cultures for reprogramming.
(D) Summary of FACS analyses for a-MHC-GFP+
cells. Effect on GFP+ cell induction with 14 factors
or the removal of individual factors from the pool of
14 factors (n = 3). Removal of Baf60c, Hand2,
Hopx, Hrt2, or Pitx2c did not decrease the percent
of GFP+ cells and were excluded for further anal-
yses. See also Figure S2.
(E) FACS plots for analyses of GFP+ cells. GFP+
cells were analyzed 1 week after 14 factor trans-
duction. The number of GFP+ cells were reduced
by removal of Gata4, but increased by removal of
Pitx2c from 14 factors.
(F–H) Effect on GFP+ cell induction of the removal
of individual factors from the pool of 9 (F), 6 (G), or 5
(H) factors (n = 3). Factors that did not decrease
efficiency upon removal were excluded from
further study.
(I) GFP+ (20%) cells were induced from fibroblasts
by the combination of four factors, Gata4, Mef2c,
Mesp1, and Tbx5. Representative data are shown
in eachpanel. PI, propidium iodine.All data are pre-
sented asmeans ± SD. *p < 0.01; **p < 0.05 versus
relevant control. Scale bars represent 100 mm.
See also Figures S1 and S2.with this, the bHLH transcription factor, Neurogenin 3, in combi-
nation with Pdx1 and Mafa, can efficiently reprogram pancreatic
exocrine cells into functional b cells in vivo, although the exocrine
cells were known to have some potential to become islet cells
in vitro and share a common parent cell with islet cells (Baeyens
et al., 2005; Zhou et al., 2008). A combination of three factors,
Ascl1, Brn2, and Myt1l, converts dermal fibroblasts to functional
neurons (Vierbuchen et al., 2010), although the degree of global
reprogramming of the neurons is unknown.
In this study, we examined whether key developmental
cardiac regulators could reprogram cardiac fibroblasts into car-
diomyocytes. We found that out of a total of 14 factors, a specific
combination of three transcription factors, Gata4, Mef2c, and
Tbx5, was sufficient to generate functional beating cardiomyo-
cytes directly from mouse postnatal cardiac or dermal fibro-
blasts and that the induced cardiomyocytes (iCMs) were globally
reprogrammed to adopt a cardiomyocyte-like gene expression
profile.376 Cell 142, 375–386, August 6, 2010 ª2010 Elsevier Inc.RESULTS
Screening for Cardiomyocyte-
Inducing Factors
We developed an assay system in
which the induction of mature cardiomyo-cytes from fibroblasts could be analyzed quantitatively by
reporter-based fluorescence-activated cell sorting (FACS) (Fig-
ure 1A). To accomplish this, we generated aMHC promoter-
driven EGFP-IRES-puromycin transgenic mice (aMHC-GFP), in
which only mature cardiomyocytes expressed the green fluores-
cent protein (GFP) (Gulick et al., 1991). We confirmed that only
cardiomyocytes, but not other cell types such as cardiac fibro-
blasts, expressed GFP in the transgenic mouse hearts and in
primary cultured neonatal mouse cardiac cells (Figure S1 avail-
able online).
To have enough cardiac fibroblasts for FACS screening, we
obtained GFP cardiac fibroblasts from neonatal aMHC-GFP
hearts by explant culture. Fibroblast-like cells migrated from
the explants after 2 days and were confluent after 1 week. The
migrating cells did not express GFP, but expressed Thy1 and
vimentin, markers of cardiac fibroblasts (Figure 1B and data
not shown) (Hudon-David et al., 2007; Ieda et al., 2009). To avoid
contamination of cardiomyocytes, we filtered the cells by cell
strainers to remove heart tissue fragments and isolated Thy1+/
GFP cells by FACS (Figure 1C). Using FACS, we confirmed that
Thy1+/GFP cells did not express cardiac troponin T (cTnT),
a specific sarcomeric marker of differentiated mature cardio-
myocytes (Figure S1) (Kattman et al., 2006). With these proce-
dures, we had no cardiomyocyte contamination in the fibroblast
culture and could generate greater than twice the number of
cardiac fibroblasts than by conventional fibroblast isolation tech-
niques (Ieda et al., 2009).
To select potential cardiac reprogramming factors, we used
microarray analyses to identify transcription factors and epige-
netic remodeling factors with greater expression in mouse
cardiomyocytes than in cardiac fibroblasts at embryonic day
12.5 (Ieda et al., 2009). Among them, we selected 13 factors
that exhibited severe developmental cardiac defects and
embryonic lethality when mutated (Figure S2). We also included
the cardiovascular mesoderm-specific transcription factor
Mesp1 because of its cardiac transdifferentiation effect in
Xenopus (David et al., 2008). We generated individual retrovi-
ruses to efficiently express each gene in cardiac fibroblasts
(Figure S2).
We transduced Thy1+/GFP neonatal mouse cardiac fibro-
blasts with a mixture of retroviruses expressing all 14 factors
or with DsRed retrovirus (negative control) (Hong et al., 2009).
We did not observe any GFP+ cells in cardiac fibroblasts 1 week
after Ds-Red retrovirus infection or 1 week of culture without any
viral infection. In contrast, transduction of all 14 factors into fibro-
blasts resulted in the generation of a small number of GFP+ cells
(1.7%), indicating the successful activation of the cardiac-
enriched aMHC gene in some cells (Figures 1D and 1E).
To determine which of the 14 factors were critical for activating
cardiac gene expression, we serially removed individual factors
from the pool of 14. Pools lacking five factors (Baf60c, Hand2,
Hopx, Hrt2, and Pitx2c) produced an increased number of
GFP+ cells, suggesting they are dispensable in this setting
(Figures 1D and 1E). Of note, removing Gata4 decreased the
percentage of GFP+ cells to 0.5%, and removing Pitx2c
increased it to 5%. Removal of the five factors listed above
resulted in an increase in the percentage of GFP+ cells to 13%
(Figure 1F). We conducted three further rounds of withdrawing
single factors from nine-, six-, and five-factor pools, removing
those that did not decrease efficiency upon withdrawal, and
found that four factors (Gata4, Mef2c, Mesp1, and Tbx5) were
sufficient for efficient GFP+ cell induction from cardiac fibro-
blasts (Figures 1F–1H). The combination of these four factors
dramatically increased the number of fibroblasts activating the
aMHC-GFP reporter to over 20% (Figure 1I).
Gata4, Mef2c, and Tbx5 Are Sufficient for
Cardiomyocyte Induction
Next, we examined the expression of cTnT by FACS. We found
that 20% of GFP+ cells expressed cTnT at high enough levels
to detect by FACS 1 week after the four-factor transduction.
Again removing individual factors from the four-factor pool in
transduction, we found that Mesp1 was dispensable for cTnT
expression (Figures 2A and 2B). In contrast, we did not observe
cTnT+ or GFP+ cells, when either Mef2c or Tbx5 was removed.
Removal of Gata4 did not significantly affect the number ofGFP+ cells, but cTnT expression was abolished, suggesting
Gata4 was also required. Whereas the combination of two
factors, Mef2c and Tbx5, induced GFP expression but not
cTnT, no combination of two factors or single factor induced
both GFP and cTnT expression in cardiac fibroblasts (Figure 2C).
These data suggested that the combination of three factors,
Gata4, Mef2c, and Tbx5, is sufficient to induce cardiac gene
expression in fibroblasts.
We found that 30%of GFP+ cells expressed cTnT 1 week after
the three-factor transduction. Next, to confirm our screening
results, we transduced cardiac fibroblasts with three factors
(Gata4, Mef2c, and Tbx5, hereafter referred to as GMT) plus
Nkx2-5, a critical factor for cardiogenesis but excluded by our
initial screening. Surprisingly, adding Nkx2-5 to GMT dramati-
cally inhibited the expression of GFP and cTnT in cardiac
fibroblasts. We also transduced cardiac fibroblasts with the
combination of Baf60c, Gata4, and Tbx5, which can transdiffer-
entiate noncardiogenic mesoderm to cardiomyocytes in mouse
embryos (Takeuchi and Bruneau, 2009). We found that this
combination did not efficiently induce cTnT or GFP expression
above that of Tbx5 alone, confirming our screening results
(Figure 2D).
To determine if other cardiac genes were enriched in GFP+
cells, we sortedGFP+ cells andGFP cells 7 days after transduc-
tion with GMT and compared gene expression of cardiomyo-
cyte-specific genes, Myh6 (a-myosin heavy chain), Actc1
(cardiac a-actin), Actn2 (actinin a2), and Nppa (natriuretic
peptide precursor type A) by quantitative RT-PCR (qPCR). We
found that these cardiac genes were upregulated significantly
more in GFP+ than in GFP cells (Figure 2E). Next, we used
immunocytochemistry to determine if cardiac proteins were
expressed in GFP+ cells. Despite the detection of cTnT in only
30% of GFP+ cells, most GFP+ cells induced with the three fac-
tors expressed sarcomeric a-actinin (a-actinin) and had well-
defined sarcomeric structures, similar to neonatal cardiomyo-
cytes (Figure 2F; Figure S1). In addition to a-actinin, some
GFP+ cells also expressed cTnT and ANF (atrial natriuretic
factor), indicating GFP+ cells expressed several cardiomyo-
cyte-specific markers (Figures 2G and 2H). We also confirmed
that neither GFP+ nor GFP cells expressed smooth muscle or
endothelial cell markers (Figure S2), suggesting specificity of
GMT effects.
Induced Cardiomyocytes Originate from Differentiated
Fibroblasts and Are Directly Reprogrammed
We next isolated neonatal cardiac fibroblasts by the conven-
tional fibroblast isolation method in which hearts were digested
with trypsin and plated on plastic dishes (Ieda et al., 2009).
More than 85% of the cells expressed Thy1, and we isolated
Thy1+/GFP cells by FACS to exclude cardiomyocyte contami-
nation (Figure 3A). Fibroblasts transduced with GMT expressed
GFP, cTnT, and actinin after 1 week at the same level as fibro-
blasts isolated from explant cultures (Figures 3B and 3C). Similar
results were obtained on introduction of GMT into adult cardiac
fibroblasts, with full formation of sarcomeric structures (Fig-
ure 3D; Figure S2).
To determine if the induced cardiomyocyte-like cells (iCMs)
were arising from a subpopulation of stem-like cells, weCell 142, 375–386, August 6, 2010 ª2010 Elsevier Inc. 377
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Figure 2. Combination of Three Transcrip-
tion Factors Induces Cardiac Gene Expres-
sion in Fibroblasts
(A) FACS analyses for a-MHC-GFP and cardiac
Troponin T (cTnT) expression. Effects of the
removal of individual factors from the pool of four
factors on GFP+ and cTnT+ cell induction.
(B) Quantitative data of GFP+ cells and cTnT+ cells
in (A) (n = 3).
(C) Effect of the transduction of pools of three, two,
and one factors on GFP+ and cTnT+ cell induction
(n = 3).
(D) FACS analyses for a-MHC-GFP and cTnT
expression. Effects of GMT plus Nkx2.5 and
Baf60c/Gata4/Tbx5 transduction are shown.
(E) The mRNA expression in GFP+ and GFP cells
7 days after GMT transduction was determined by
qPCR (n = 3).
(F) Immunofluorescent staining for GFP, a-actinin,
and DAPI. The combination of the three factors,
GMT, induced abundant GFP, and a-actinin
expression in cardiac fibroblasts 2 weeks after
transduction. High-magnification views in insets
show sarcomeric organization. See also Figures
S1 and S2.
(G) Induced cardiomyocytes expressed cTnT by
immunocytochemistry with clear sarcomeric orga-
nization 4 weeks after transduction. Insets are
high-magnification views.
(H) Induced cardiomyocytes expressed ANF at
perinuclear sites 2 weeks after transduction.
All data are presented as means ± SD. *p < 0.01
versus relevant control. Scale bars represent
100 mm.
See also Figures S1 and S2.analyzed c-kit expression (Beltrami et al., 2003) in the Thy1+/
GFP cells. Most c-kit+ cells coexpressed Thy1, whereas 15%
of Thy1+ cells expressed c-kit, which is consistentwith aprevious
report of cardiac explant-derived cells (Davis et al., 2009). We
isolated GFP/Thy1+/c-kit+ cells and GFP/Thy1+/c-kit cells
by FACS and transduced each population of cells with GMT.
We found 2–3-fold more cardiomyocyte induction in GFP/
Thy1+/c-kit cells than in GFP/Thy1+/c-kit+ cells (Figure S3).
These results suggest that most of the iCMs originated from
a c-kit-negative population.
We then sought to more definitively exclude the possibility of
rare cardiac progenitors giving rise to iCMs. We tested the
potential of mouse tail-tip dermal fibroblasts to generate iCMs.
We found that sorted Thy1+/GFP tail-tip dermal fibroblasts
transduced with GMT expressed GFP at the same level as
GMT-transduced cardiac fibroblasts, although the percentage
of cTnT+ cells was less than cardiac fibroblast-derived iCMs378 Cell 142, 375–386, August 6, 2010 ª2010 Elsevier Inc.(Figures 3E–3G). Like cardiac fibroblasts,
tail-tip fibroblast-derived GFP+ cells ex-
pressed a-actinin and had well-defined
sarcomeric structures (Figure 3H; Fig-
ure S3), suggesting noncardiac fibro-
blasts can also be reprogrammed into
cardiomyocytes by GMT induction.These results excluded the possibility that the iCMs arose from
contamination of cardiomyocytes or cardiac progenitors before
cardiac induction in the fibroblast population.
We also determined whether the reprogramming of fibroblasts
to differentiated cardiomyocytes was a direct event or if the
fibroblasts first passed through a cardiac progenitor cell fate
before further differentiation. To distinguish between these two
possibilities, we used mice expressing Isl1–yellow fluorescent
protein (YFP) obtained by crossing Isl1-Cre mice and R26R-
EYFP mice (Srinivas et al., 2001) (Figure S3). Isl1 is an early
cardiac progenitor marker that is transiently expressed before
cardiac differentiation. If iCMs generated from fibroblasts
passed through a cardiac progenitor state, they and their
descendants would permanently express YFP (Laugwitz et al.,
2005). We isolated Isl1-YFP/Thy1+cells from Isl1-YFP heart
explants by FACS and transduced the cells with GMT. The
resulting cTnT+ cells did not express YFP in significant numbers,
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Figure 3. Induced Cardiomyocytes Origi-
nate from Differentiated Fibroblasts and
Are Directly Reprogrammed
(A) Cardiac fibroblasts (CF) isolated by the conven-
tional isolation method. Most cells were positive
for Thy1, and Thy-1+/GFP cells were sorted by
FACS for transduction.
(B) FACS analyses for aMHC-GFP and cTnT
expression in cardiac fibroblasts isolated in (A)
1 week after transduction by GMT.
(C) Immunofluorescent staining for GFP, a-actinin,
and DAPI in the GMT induced cardiomyocytes
originated from (A).
(D) Cardiac fibroblasts isolated from adult aMHC-
GFP hearts were transduced with three factors.
See also Figure S2.
(E) Thy-1+/GFP tail-tip dermal fibroblasts (TTFs)
were sorted by FACS for transduction.
(F) FACS analyses for GFP and cTnT expres-
sion in TTFs isolated in (E) 1 week after GMT
transduction.
(G) Quantitative data of GFP+ cells and cTnT+ cells
indicated in (F) (n = 3 in each group).
(H) Immunofluorescent staining for GFP, a-actinin,
and DAPI in TTF-derived iCMs. See also Figure S3.
(I) Isl1-YFP/Thy1+cells were sorted from Isl1-Cre/
Rosa-YFP heart explants and transduced with
GMT. See also Figure S3.
(J) The vast majority of cTnT+ cells induced from
Isl1-YFP/Thy1+cells was negative for YFP.
(K) Mesp1-YFP/Thy1+cells were sorted from
Mesp1-Cre/Rosa-YFP TTFs and transduced with
GMT. See also Figure S3.
(L) All cTnT+ cells induced from Mesp1-YFP/
Thy1+cells were negative for YFP.
All data are presented as means ± SD. *p < 0.01
versus relevant control. Scale bars represent
100 mm. See also Figure S3 for analyses of c-kit+
cells.
See also Figures S2 and S3.suggesting that the iCMs were not first reprogrammed into Isl1+
cardiac progenitor cells (Figures 3I and 3J). Moreover, these
results provided supportive evidence that the iCMs did not orig-
inate from a rare population of cardiac progenitor cells that might
exist in neonatal hearts.
Whereas Isl1 marks most early cardiac progenitors, a subpop-
ulation of cardiac progenitors remains Isl1 negative. Mesp1 is
the earliest pan-cardiovascular progenitor cell marker that is
transiently expressed in nascent mesoderm before further
cardiovascular differentiation (Figure S3) (Saga et al., 1999).
We therefore generated Mesp1-YFP mice by crossing Mesp1-
Cre and R26R-EYFP mice to determine if iCMs were reprog-
rammed into early cardiac mesoderm before further differentia-
tion. We isolated Mesp1-YFP/Thy1+ tail-tip dermal fibroblasts
by FACS and transduced the cells with GMT (Figures 3K andCell 142, 375–383L). The resulting cTnT+ cells did not
express YFP, suggesting that the iCMs
were not converted into the cardiac
mesoderm cell state for reprogramming,
but rather they were directly reprog-rammed into differentiated cardiomyocytes by the three factors
(Figure 3L).
Induced Cardiomyocytes Resemble Postnatal
Cardiomyocytes in Global Gene Expression
We next analyzed the time course of cardiomyocyte induction
from cardiac fibroblasts. GFP+ cells were detected 3 days after
induction and gradually increased in number up to 20% at day
10 and were still present after 4 weeks (Figure 4A). GFP+ cells
were less proliferative than GFP cells and, over time, decreased
in percentage relative to the total number of cells. Importantly, the
percentage of cTnT+ cells among the a-MHC-GFP+ iCMs and the
intensity of cTnT expression increased significantly over time
(Figures 4B and 4C). We sorted GFP+ cells at 1, 2, and 4 weeks
after transduction with GMT and compared cardiac gene6, August 6, 2010 ª2010 Elsevier Inc. 379
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Figure 4. Gene Expression of Induced Car-
diomyocytes Is Globally Reprogrammed
(A) The percent of aMHC-GFP+ cells after GMT
transduction (n = 3). The number of GFP+ cells
was counted by FACS at each time point and
divided by the number of plated cells.
(B) FACS analyses of percent of cells with cTnT
expression among aMHC-GFP+ iCMs. Note that
cTnT + cell number and cTnT intensity were both
increased over time (n = 4).
(C) Quantitative data of cTnT intensity in (B) (n = 4).
(D) Actc1, Myh6, Ryr2, Gja1, and Col1a2 mRNA
expression in cardiac fibroblasts (CF), induced
cardiomyocytes (iCMs) (1 week (W), 2 W, 4 W after
transduction), and neonatal cardiomyocytes (CM),
determined by qPCR (n = 3).
(E) Heatmap image of microarray data illustrating
differentially expressed genes among CF, a-
MHC-GFP, iCMs (FACS sorted 2 and 4 weeks
after transduction), and CM (n = 3 in each group).
The scale extends from 0.25- to 4-fold over
mean (2 to +2 in log2 scale). Red indicates
increased expression, whereas green indicates
decreased expression. Group 1 includes the
genes upregulated only in CM, and group 2
includes the genes upregulated in CM and 4W-
iCMs compared to CF. Lists of genes are shown
in Table S1 and Table S2. All data are presented
as means ± SD. *p < 0.01; **p < 0.05 versus rele-
vant control. See also Figure S4 for endogenous
and exogenous expression of reprogramming
factors and Table S1 and Table S2 for differentially
expressed genes.
See also Tables S1 and S2 and Figure S4.expression with cardiac fibroblasts and neonatal cardiomyo-
cytes. The cardiomyocyte-specific genes, Actc1, Myh6, Ryr2
(ryanodine receptor 2), and Gja1 (connexin43), were significantly
upregulated in a time-dependent manner in GFP+ cells, but
were not detected in cardiac fibroblasts by qPCR (Figure 4D).
Col1a2 (collagen 1a2), a marker of fibroblasts, was dramatically
downregulated in GFP+ cells from 7-day culture to the same level
as in cardiomyocytes. These data indicated that the three factors
induced direct conversion of cardiac fibroblasts to cardiomyo-
cytes rapidly and efficiently, but full maturation was a slow
process that occurred over several weeks. Total gene expression
of the three reprogramming factorswasupregulated6- to8-fold in
iCMs over neonatal cardiomyocytes. However, only endogenous
expression ofGata4wasupregulated in iCMs to the same level as
in neonatal cardiomyocytes, whereas endogenous Mef2c and
Tbx5 expression was lower in iCMs than in cardiomyocytes,
potentially reflecting negative autoregulatory loops (Figure S4).380 Cell 142, 375–386, August 6, 2010 ª2010 Elsevier Inc.We next compared the progressive
global gene expression pattern of iCMs,
neonatal cardiomyocytes, and cardiac
fibroblasts by mRNA microarray anal-
yses. We sorted GFP+ cells and GFP
cells 2 and 4 weeks after GMT transduc-
tion. The iCMs at both stages were similar
to neonatal cardiomyocytes, but weredistinct from GFP cells and cardiac fibroblasts in global gene
expression pattern (Figure 4E). We found that functionally impor-
tant cardiac genes were upregulated significantly more in 4 week
iCMs than in 2 week iCMs, including Pln (phospholamban),
Slc8a1 (sodium/calcium exchanger), Myh6, Sema3a (sema-
phorin 3a), Id2 (inhibitor ofDNAbinding 2), andMyl2 (myosin, light
polypeptide 2, regulatory, cardiac, slow, also known as MLC2v)
(Table S1). Conversely, some genes were downregulated more
in 4week iCMs than in 2week iCMs (TableS1). Thearray analyses
also identified genes that were upregulatedmore in neonatal car-
diomyocytes than in 4 week iCMs or cardiac fibroblasts (group 1
in Figure 4E), including Bmp10 (bonemorphogenetic protein 10),
Erbb4 (v-erb-a erythroblastic leukemia viral oncogene homolog
4), Irx4 (Iroquois related homeobox 4), and Atp1a2 (ATPase,
Na+/K+ transporting, a 2 polypeptide) (Table S2). We also identi-
fied genes that were expressed to a greater extent in both cardi-
omyocytes and 4 week iCMs than in fibroblasts (group 2 in
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Figure 5. Fibroblasts Are Stably Reprog-
rammed into iCMs by Gata4, Mef2c, and
Tbx5
(A) The promoters of Actn2, Ryr2, and Tnnt2 were
analyzed by ChIP for trimethylation status of
histone H3 of lysine 27 or 4 in cardiac fibroblasts
(CF), CF-derived iCMs, tail-tip fibroblasts (TTF),
TTF-derived iCMs, and neonatal cardiac cells.
Data were quantified by qPCR.
(B) The promoters of Nppa and Myh6 were
analyzed with bisulfite genomic sequencing for
DNAmethylation status in CF, a-MHC-GFP cells,
a-MHC-GFP+ iCMs (FACS sorted 4 weeks after
transduction), and neonatal CM. Open circles indi-
cate unmethylated CpG dinucleotides; closed
circles indicate methylated CpGs.
(C) Schematic representation of the strategy to
test expression kinetics of the doxycycline (Dox)-
inducible lentiviral system.
(D) Wild-type TTFs were infected with pLVX-tetO-
GFP and pLVX-rtTA and imaged before (off Dox),
1 day after Dox addition, and at time points after
Dox withdrawal (–Dox). All images were taken
using constant exposure times and identical
camera settings.
(E) Schematic representation of the strategy to
determine temporal requirement of Gata4/Mef2c/
Tbx5 in reprogramming. Thy1+/GFP TTF were
infected with the pLVX-tetO-GMT and pLVX-rtTA
lentiviruses, and Dox was added for 2 weeks and
thereafter withdrawn for 1 week.
(F) Immunofluorescent staining for GFP, a-actinin,
and DAPI in iCMs 2 weeks after lentiviral infection
and Dox induction.
(G) Immunofluorescent staining for GFP, a-actinin,
and DAPI 1 week after Dox withdrawal. iCMs
maintained a-MHC GFP expression and had
a-actinin positive sarcomeric structures. High-
magnification views in insets show sarcomeric
organization. Representative data are shown in
each panel. All data are presented as means ±
SD. *p < 0.01; **p < 0.05 versus relevant control.
Scale bars represent 100 mm.Figure 4E), including Actc1, Myl7 (myosin, light polypeptide 7,
regulatory, also known as MLC2a), Tnnt2 (troponin T2, cardiac),
Tbx3 (T-box 3), and Srf (serum response factor) (Table S2).
Thus, iCMswere similar, but not identical, to neonatal cardiomyo-
cytes, and the reprogramming event was broadly reflected in
global gene expression changes.
Fibroblasts Are Epigenetically Reprogrammed
to a Cardiomyocyte-like State by Gata4/Mef2c/Tbx5
To determine if iCMs have gained a cardiomyocyte-like chro-
matin state, we analyzed the enrichment of histonemodifications
in the promoter regions of the cardiac-specific genes Actn2,
Ryr2I, and Tnnt2. We analyzed the enrichment of trimethylated
histone H3 of lysine 27 (H3K27me3) and lysine 4 (H3K4me3),
which mark transcriptionally inactive or active chromatin,
respectively (Li et al., 2007), in cardiac fibroblasts, 4 weekiCMs, and neonatal cardiac cells by chromatin immunoprecipita-
tion, followed by qPCR (Figure 5A). After reprogramming,
H3K27me3 was significantly depleted at the promoters of all
the genes analyzed in iCMs, reaching levels comparable to those
in cardiac cells, whereas H3K4me3 increased on the promoter
regions of Actn2 and Tnnt2 in iCMs, as compared with cardiac
fibroblasts. Ryr2 had similar levels of H3K4me3 in iCMs as in
fibroblasts, suggesting that its activation reflects the resolution
of a ‘‘bivalent’’ chromatin mark (Bernstein et al., 2006). These
results suggested that cardiac fibroblast-derived iCMs gained
a chromatin status similar to cardiomyocytes at least in some
cardiac specific genes. Intriguingly, H3K27me3 levels were
higher in tail-tip fibroblasts than cardiac fibroblasts on all three
genes analyzed and, despite a significant reduction upon
reprogramming to iCMs, remained somewhat higher than in
cardiac cells and cardiac fibroblast-derived iCMs.Cell 142, 375–386, August 6, 2010 ª2010 Elsevier Inc. 381
The DNA methylation status of specific loci also reflects the
stability of the reprogramming event and we therefore investi-
gated such changes during reprogramming from cardiac fibro-
blasts to iCMs. We performed bisulfite genomic sequencing in
the promoter regions of Nppa and Myh6 in cardiac fibroblasts,
4 week GFP cells, iCMs, and neonatal cardiomyocytes. Both
promoter regions were hypermethylated in cardiac fibroblasts
and GFP cells, as expected from the cardiomyocyte-specific
expression of these genes, but were comparatively demethy-
lated in iCMs, similar to neonatal cardiomyocytes (Figure 5B).
These results indicated that reprogramming by Gata4, Mef2c,
and Tbx5 induced epigenetic resetting of the fibroblast genome
to a cardiomyocyte-like state.
To further assess the stability of the reprogramming event, we
generated a doxycycline-inducible lentiviral system in which
transgene expression of the reprogramming factors was con-
trolled by doxycycline administration. We first transduced wild-
type tail-tip fibroblasts with a mixture of lentiviruses containing
pLVX-tetO-GFP and pLVX-rtTA to determine the expression
kinetics of this system (Figure 5C). We confirmed that the
majority of fibroblasts infected with both viruses expressed
GFP within 1 day after doxycycline induction, and the GFP
expression was instantly diminished by withdrawal of doxycy-
cline and disappeared within 6 days (Figure 5D). Thy1+/GFP
tail-tip fibroblasts were harvested from aMHC-GFP neonatal
mice, transduced with a pool of lentiviruses containing inducible
Gata4, Mef2c, and Tbx5, along with pLVX-rtTA, and subse-
quently treated with doxycycline (Figure 5E). We found that
aMHC-GFP expression was induced from tail-tip fibroblasts
after doxycycline administration and that the iCMs had well-
defined sarcomeric structures marked with an anti-a-actinin
antibody after 2 weeks of culture (Figure 5F). Doxycycline was
withdrawn after 2 weeks of culture, and cells were subsequently
cultured without doxycycline for 1 week to fully remove exoge-
nous expression of the reprogramming factors (Figure 5E). The
iCMs maintained aMHC-GFP expression and had sarcomeric
structures after doxycycline withdrawal, suggesting that the
fibroblasts were stably reprogrammed into iCMs after 2 weeks
exposure to Gata4, Mef2c, and Tbx5 (Figure 5G).
Induced Cardiomyocytes Exhibit
Spontaneous Contraction
To determine if iCMs possessed the functional properties char-
acteristic of cardiomyocytes, we analyzed intracellular Ca2+
flux in iCMs after 2–4 weeks of culture. Around 30% of cardiac
fibroblast-derived iCMs showed spontaneous Ca2+ oscillations
and their frequencywas variable, resembling what was observed
in neonatal cardiomyocytes (Figures 6A, 6B, and 6D; Movie S1).
We observed that tail-tip dermal fibroblast-derived iCMs also
exhibited spontaneous Ca2+ oscillations, but the oscillation
frequency was lower than that of cardiomyocytes and cardiac
fibroblast-derived iCMs (Figures 6C and 6E; Movie S2).
In addition to the characteristic Ca2+ flux, cardiac fibroblast-
derived iCMs showed spontaneous contractile activity after
4–5 weeks in culture (Movies S3 and S4; Figure S5). Single-cell
extracellular recording of electrical activity in beating cells
revealed tracings similar to the potential observed in neonatal
cardiomyocytes (Figure 6F). Intracellular electrical recording of382 Cell 142, 375–386, August 6, 2010 ª2010 Elsevier Inc.iCMs displayed action potentials that resembled those of adult
mouse ventricular cardiomyocytes (Figure 6G). Thus, the reprog-
ramming of fibroblasts to iCMs was associated with global
changes in gene expression, epigenetic reprogramming, and
the functional properties characteristic of cardiomyocytes.
Transplanted Cardiac Fibroblasts Transduced
with Gata4/Mef2c/Tbx5 Reprogram In Vivo
To investigate whether GMT-transduced cardiac fibroblasts can
be reprogrammed to express cardiomyocyte-specific genes in
their native environment in vivo, we harvested GFP/Thy1+
cardiac fibroblasts 1 day after viral transduction and injected
them into immunosuppressed NOD-SCID mouse hearts. GMT-
infected cells did not express GFP at the time of transplantation
(Figure 4A). Cardiac fibroblasts were infected with either the
mixture of GMT and DsRed retroviruses or DsRed retrovirus
(negative control) to be readily identified by fluorescence.
Cardiac fibroblasts infected with DsRed did not express a-acti-
nin or GFP, confirming cardiomyocyte conversion did not
happen in the negative control (Figures 7A and 7B). Despite
being injected into the heart only 1 day after viral infection,
a subset of cardiac fibroblasts transduced with GMT and DsRed
expressed GFP in the mouse heart within 2 weeks (Figure 7B).
Importantly, the GFP+ cells expressed a-actinin and had sarco-
meric structures (Figure 7C). These results suggested that
cardiac fibroblasts transduced with Gata4, Mef2c, and Tbx5
can reprogram to cardiomyocytes within 2 weeks upon trans-
plantation in vivo.
DISCUSSION
Here we demonstrated that the combination of three transcrip-
tion factors, Gata4, Mef2c, and Tbx5, can rapidly and efficiently
induce cardiomyocyte-like cells from postnatal cardiac and
dermal fibroblasts. iCMs were similar to neonatal cardiomyo-
cytes in global gene expression profile, electrophysiologically,
and could contract spontaneously, demonstrating that func-
tional cardiomyocytes can be generated from differentiated
somatic cells by defined factors. Although much refinement
and characterization of the reprogramming process will be
necessary, the findings reported here raise the possibility of
reprogramming the vast pool of endogenous fibroblasts that
normally exists in the heart into functional cardiomyocytes for
regenerative purposes.
The three reprogramming factors, Gata4, Mef2c, and Tbx5,
are core transcription factors during early heart development
(Olson, 2006; Srivastava, 2006; Zhao et al., 2008). They interact
with one another, coactivate cardiac gene expression (e.g.,
Nppa, Gja5 [Cx40], and Myh6), and promote cardiomyocyte
differentiation (Bruneau et al., 2001; Garg et al., 2003; Ghosh
et al., 2009; Lin et al., 1997). Gata4 is considered a ‘‘pioneer’’
factor and might open chromatin structure in cardiac loci (Cirillo
et al., 2002), thus allowing binding of Mef2c and Tbx5 to their
specific target sites and leading to full activation of the cardiac
program. Although the reprogramming event appears stable at
the epigenetic level, as marked by histone methylation and
DNA methylation, the global gene expression of iCMs is similar
but not identical to neonatal cardiomyocytes. Whether they are
AB
D
αMHC-GFP Ca2+ max Ca2+ min
C Rhod-3 intensity
(Tail tip fibroblast-derived iCMs)
E
Ca2+ max Ca2+ min
Tail tip fibroblast-derived iCMs
Cardiac fibroblast-derived iCMs
F
Rhod-3 intensity (Neonatal cardiomyocytes)
1 s 1 s
Rhod-3 intensity (Cardiac fibroblast-derived iCMs)
1 s 1 s
GCardiac fibroblast-derived iCMs
extracellular electrical recording
50 ms
20
 m
V
0 mV
0 mV
Cardiac fibroblast-derived iCMs
Adult mouse ventricular cardiomyocytes
50 ms
20
 m
V
1 s
Ca2+ max Ca2+ min
Neonatal cardiomyocytes
1 s
2 
m
V
Neonatal cardiomyocytes
extracellular electrical recording
1 s
2 
m
V
αMHC-GFP
Figure 6. Induced Cardiomyocytes Exhibit
Spontaneous Ca2+ Flux, Electrical Activity,
and Beating
(A and B) Cardiac fibroblast (CF)-derived iCMs
showed spontaneous Ca2+ oscillation with varying
frequency (A), similar to neonatal cardiomyocytes
(B). Rhod-3 intensity traces are shown.
(C) Tail-tip dermal fibroblast (TTF)-derived iCMs
showed spontaneous Ca2+ oscillation with lower
frequency. The Rhod-3 intensity trace is shown.
(D) Spontaneous Ca2+ waves observed in CF-
derived a-MHC-GFP+ iCMs (white dots) or
neonatal cardiomyocytes (arrows) with Rhod-3 at
Ca2+ max and min is shown. Fluorescent images
correspond to the Movie S1.
(E) Spontaneous Ca2+ oscillation observed in the
TTF-derived a-MHC-GFP+ iCMs with Rhod-3 at
Ca2+ max and min is shown. Fluorescent images
correspond to the Movie S2.
(F) Spontaneously contracting iCMs had electrical
activity measured by single cell extracellular elec-
trodes. Neonatal cardiomyocytes showed similar
electrical activity.
(G) Intracellular electrical recording of CF-derived
iCMs cultured for 10 weeks displayed action
potentials that resembled those of adult mouse
ventricular cardiomyocytes. Representative data
are shown in each panel (n = 10 in A–F, n = 4 in
G). See also Figure S5 and Movies S1, S2, S3
and S4.
See also Movies S1, S2, S3, and S4 and Figure S5.more similar to adult ventricular cardiomyocytes or other
subpopulations remains to be determined. Additional epigenetic
regulators, microRNAs, or signaling proteins may be leveraged
to increase the efficiency and robustness of the reprogramming
event. Furthermore, other combinations of factors likely also
induce cardiac reprogramming, much like the experience in the
iPSC field.
Several lines of evidence suggest that the iCMs we describe
here originated from differentiated fibroblasts. We found that
any potential rare cardiac ‘‘progenitor-like’’ cells, marked by
c-kit or Isl1, were dispensable for cardiomyocyte induction
(Beltrami et al., 2003). Furthermore, the high efficiency of
cardiac induction (up to 20%) does not favor the interpretation
that rare stem or progenitor cells were the origin of induced
cardiomyocytes. Most importantly, the ability to reprogram
dermal fibroblasts into iCMs supports the conclusion that
cardiac progenitors are not the target cells for the reprogram-Cell 142, 375–38ming factors. Remarkably, reprogram-
ming of cardiac fibroblasts to myocytes
occurred in a relatively short period,
with the first GFP+ cells appearing at
day 3, in contrast to iPSC reprogram-
ming, which typically takes 10–20 days
and occurs with much lower efficiency
(<0.1%) (Takahashi and Yamanaka,
2006). Despite the early initiation of
reprogramming, the process appears to
continue for several weeks, with progres-sive changes in gene expression, contractile ability, and electro-
physiologic maturation.
Although many questions remain regarding the mechanisms
of reprogramming, we were able to genetically test the ‘‘route’’
of cell fate alteration. Our findings suggest that cardiomyocytes
were directly induced from cardiac fibroblasts without reverting
to a cardiac progenitor cell state, which may explain the rapid
early reprogramming process. This conclusion was supported
by the absence of Isl1-Cre-YFP or Mesp1-Cre-YFP activation
during the process of reprogramming, which would havemarked
any cells that transiently expressed Isl1 or Mesp1 (Laugwitz
et al., 2005; Saga et al., 1999).
The ability to reprogram endogenous cardiac fibroblasts into
cardiomyocytes has many therapeutic implications. First, the
avoidance of reprogramming to pluripotent cells before cardiac
differentiation would greatly lower the risk of tumor formation
in the setting of future cell-based therapies. Second, large6, August 6, 2010 ª2010 Elsevier Inc. 383
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Figure 7. Transplanted Cardiac Fibroblasts Trans-
duced with Gata4/Mef2c/Tbx5 Can Be Reprog-
rammed to Cardiomyocytes In Vivo
(A) DsRed infected cardiac fibroblasts (DsRed-cell) were
transplanted into NOD-SCID mouse hearts 1 day after
infection and cardiac sections were analyzed by immuno-
cytochemistry after 2 weeks. Transplanted fibroblasts
marked with DsRed did not express a-actinin (green).
(B) Cardiac fibroblasts infected with DsRed or Gata4/
Mef2c/Tbx5 with DsRed (GMT/DsRed-cell) were trans-
planted into NOD-SCID mouse hearts 1 day after infection
and visualized by histologic section. Note that a subset of
GMT/DsRed cells expressed a-MHC-GFP. Data were
analyzed 2 weeks after transplantation.
(C) Gata4/Mef2c/Tbx5-transduced cardiac fibroblasts
(GMT-cell) were transplanted into mouse hearts and histo-
logic sections analyzed. A subset of induced GFP+ cells
expressed a-actinin (red) and had sarcomeric structures.
Insets are high-magnification views of cells indicated by
arrows. Data were analyzed 2 weeks after transplantation.
Representative data are shown in each panel (n = 4 in each
group). Scale bars represent 100 mm. Note that GMT/
DsRed or GMT-infected cells did not express GFP at the
time of transplantation (Figure 4A).amounts of an individual’s own fibroblasts can be grown from
a cardiac biopsy or skin biopsy in vitro for transduction with
the defined factors, followed by delivery of cells to damaged
hearts. Third, and most promising, is the potential to introduce
the defined factors, or factors that mimic their effects, directly
into the heart to reprogram the endogenous fibroblast popula-
tion, which represents more than 50% of the cells, into new car-
diomyocytes that can contribute to the overall contractility of the
heart. Our observation that injection of fibroblasts into the heart
only 1 day after induction of Gata4/Mef2c/Tbx5 resulted in
reprogramming of the transplanted cells suggests that this
may be possible. Future studies in human cells and advances
in safe delivery of defined factors will be necessary to advance
this technology for potential regenerative therapies.EXPERIMENTAL PROCEDURES
Generation of aMHC-GFP, Isl1-YFP, and Mesp1-YFP Mice
To generate aMHC-GFP mice, EGFP-IRES-Puromycin cDNA was subcloned
into the expression vector containing a-myosin heavy chain promoter (Gulick
et al., 1991). Pronuclear microinjection and other procedures were performed
according to the standard protocols (Ieda et al., 2007). PCR primers are listed
in the Extended Experimental Procedures. Isl1-YFP mice were obtained by
crossing Isl1-Cre mice and R26R-EYFP mice (Srinivas et al., 2001). Mesp1-
YFP mice were obtained by crossing Mesp1-Cre mice and R26R-EYFP mice
(Saga et al., 1999).384 Cell 142, 375–386, August 6, 2010 ª2010 Elsevier Inc.Cell Culture
For explant culture, isolated neonatal or adult mouse
hearts were minced into small pieces less than 1 mm3 in
size. The explants were plated on gelatin-coated dishes
and cultured for 7 days in explant medium (IMDM/20%
FBS) (Andersen et al., 2009). Migrated cells were har-
vested and filtered with 40 mm cell strainers (BD) to avoid
contamination of heart tissue fragments. aMHC-GFP/
Thy1+, Isl1-YFP/Thy1+, aMHC-GFP/Thy1+/c-kit, or
aMHC-GFP/Thy1+/c-kit+ live cells (as defined by thelack of propidium iodine staining) were isolated using FACS Aria 2 (BD Biosci-
ences). For conventional isolation of neonatal cardiac fibroblasts, hearts were
digested with 0.1% trypsin and plated on plastic dishes (Ieda et al., 2009).
For isolation of tail-tip fibroblasts, tails were digested with 0.1% trypsin and
plated on plastic dishes. Attached fibroblasts were cultured for 7 days and
aMHC-GFP/Thy1+ or Mesp1-YFP/Thy1+ cells were sorted and cultured in
DMEM/M199 medium containing 10% FBS at a density of 104/cm2. Cells
were transduced by retroviruses or lentiviruses after 24 hr.
Isolation of Cardiomyocytes
To isolate cardiomyocytes, neonatal aMHC-GFP+ ventricles were cut into
small pieces and digested with collagenase type II solution (Ieda et al.,
2009). A single-cell suspension was obtained by gentle triturating and passing
through a 40 mm cell strainer. aMHC-GFP+ live cells were isolated by FACS
Aria 2. To obtain cardiac cells, cells were plated on gelatin-coated plastic
dishes and treated with Ara C (Sigma) to inhibit nonmyocyte proliferation.
Molecular Cloning and Retroviral/Lentiviral Infection
Retroviruses or inducible lentiviruses containing the cardiac developmental
factors were generated as described and as detailed in the Extended Experi-
mental Procedures (Kitamura et al., 2003; Takahashi and Yamanaka, 2006).
The pMXs-DsRed Express retrovirus infection in cardiac fibroblasts resulted
in >95% transduction efficiency (Hong et al., 2009).
FACS Analyses and Sorting
For GFP expression analyses, cells were harvested from cultured dishes and
analyzed on a FACS Calibur (BD Biosciences) with FlowJo software. For
aMHC-GFP/cTnT expression, cells were fixed with 4% PFA for 15 min, per-
meabilized with Saponin, and stained with anti-cTnT and anti-GFP antibodies,
followed by secondary antibodies conjugated with Alexa 488 and 647 (Katt-
man et al., 2006).
For aMHC-GFP/Thy1+, Isl1-YFP/Thy1+, and Mesp1-YFP/Thy1+ cell
sorting, cells were incubated with PECy7 or APC-conjugated anti-Thy1
antibody (eBioscience) and sorted by FACS Aria 2 (Ieda et al., 2009).
For aMHC-GFP/Thy1+/c-kit and aMHC-GFP/Thy1+/c-kit+ cell sorting,
PECy7-conjugated anti-Thy1 and APC-conjugated anti-c-kit antibodies
(BD) were used. We used bone marrow cells as a positive control for c-kit
staining.
Cell Transplantation
Fibroblasts were harvested 1 day after retroviral infection. A left thoracotomy
was carried out in NOD-SCID mice, and 106 cultured cells were injected
into the left ventricle. After 1–2 weeks, the hearts were excised for
immunohistochemistry.
Histology and Immunocytochemistry
Cells or tissues were fixed, processed and stained with antibodies against
numerous proteins in standard fashion as detailed in the Extended Experi-
mental Procedures.
Quantitative RT-PCR
Total RNA was isolated from cells, and qRT-PCR was performed on an ABI
7900HT (Applied Biosystems) with TaqMan probes (Applied Biosystems),
which are listed in the Extended Experimental Procedures. To quantify endog-
enous-specific transcripts and both endogenous and transgene common tran-
scripts, primers were designed using Vector NTI, and SYBR green technology
was used. Primer information is available on request. mRNA levels were
normalized by comparison to Gapdh mRNA.
Microarray Analyses
Mouse genome-wide gene expression analyses were performed using
Affymetrix Mouse Gene 1.0 ST Array. aMHC-GFP+ cardiomyocytes were
collected by FACS. Three-factor transduced GFP+ cells and GFP cells
were collected by FACS after 2 and 4 weeks of culture. Cardiac fibroblasts
were also collected after 4 weeks of culture. RNA was extracted using Pico-
Pure RNA Isolation (Arcturus). Microarray analyseswere performed in triplicate
from independent biologic samples, according to the standard Affymetrix
Genechip protocol. Data were analyzed using the Affymetrix Power Tool
(APT, version 1.8.5). See the Extended Experimental Procedures for additional
statistical methods.
Chromatin Immunoprecipitation Assay
Chromatin immunoprecipitations were performed on cardiac fibroblasts, tail-
tip dermal fibroblasts, iCMs, and neonatal cardiac cells. Immunoprecipitations
were done using the Imprint Chromatin Immunoprecipitation Kit (Sigma)
following the manufacturer instructions. Antibodies against H3K27me3 and
H3K4me3 were from Active motif, and normal rabbit IgG was from Cell
Signaling Technology. Primer sequences for qPCR custom TaqMan gene
expression assays (Applied Biosystems) are listed in the Extended Experi-
mental Procedures.
Bisulfite Genomic Sequencing
Bisulfite treatment was performed using the Epitect Bisulfite Kit (QIAGEN)
according to the manufacturer’s recommendations. PCR primers are listed
in the Extended Experimental Procedures. Amplified products were cloned
into pCR2.1-TOPO (Invitrogen). Ten randomly selected clones were
sequenced with the M13 forward and M13 reverse primers for each gene.
Ca2+ Imaging
Ca2+ imaging was performed according to the standard protocol. Briefly, cells
were labeled with Rhod-3 (Invitrogen) for 1 hr at room temperature, washed,
and incubated for an additional 1 hr to allow de-esterification of the dye.
Rhod-3-labeled cells were analyzed by Axio Observer (Zeiss) with MiCAM02
(SciMedia).Electrophysiology
After 4 week transduction with GMT, the electrophysiological activities of iCMs
were analyzed using extracellular electrode recording with an Axopatch 700B
amplifier and the pClamp9.2 software (Axon Instruments). iCMs were visually
identified by GFP expression and spontaneous contraction. Glass patch
pipettes, with typical resistances of 2–4 MU, were directly attached on single
GFP+ cells for extracellular recording in Tyrode’s bath solution. For recording
intracellular action potentials, single GFP+ cells were held at 70 mV
membrane potential with a stimulation of 0.1–0.5 nA for 5 ms to elicit
a response after 10-week transduction with GMT.
Statistical Analyses
Differences between groups were examined for statistical significance using
Student’s t test or ANOVA. p values of <0.05 were regarded as significant.
ACCESSION NUMBERS
Microarray data have been submitted and can be accessed by the Gene
Expression Omnibus (GEO) accession number GSE22292.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five
figures, two tables, and four movies and can be found with this article online
at doi:10.1016/j.cell.2010.07.002.
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